Abcellera Biologics Inc.

Biotechnology • Healthcare • Vancouver, BC, United States • ABCL (NMS)

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Wikipedia

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

AbCellera Biologics (NASDAQ:ABCL) Cut to Sell at Wall Street Zen - MarketBeat

MarketBeat • Jan 4

Will AbCellera’s (ABCL) Bruker Patent Settlement and Royalties Shift Its Long-Term Revenue Narrative? - simplywall.st

simplywall.st • Dec 20

AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results - Yahoo Finance

Yahoo Finance • Dec 4

AbCellera Biologics Stock (ABCL) Opinions on Recent Price Surge - Nasdaq

Nasdaq • Jul 21

AbCellera biologics director Montalbano buys $178k in shares - Investing.com

Investing.com • Nov 26

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has AbCellera Biologics Inc. had layoffs?

No layoff events have been recorded for AbCellera Biologics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does AbCellera Biologics Inc. have?

AbCellera Biologics Inc. has approximately 596 employees.

What industry is AbCellera Biologics Inc. in?

AbCellera Biologics Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is AbCellera Biologics Inc. a publicly traded company?

Yes, AbCellera Biologics Inc. is publicly traded under the ticker symbol ABCL on the NMS. The company has a market capitalization of approximately $1.11 billion.

Where is AbCellera Biologics Inc. headquartered?

AbCellera Biologics Inc. is headquartered in Vancouver, BC, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.